ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 71 filers reported holding ATHIRA PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $286,979 | -33.8% | 142,069 | -3.3% | 0.00% | -100.0% |
| Q2 2023 | $433,559 | +26.4% | 146,969 | +7.1% | 0.00% | 0.0% |
| Q1 2023 | $342,923 | -26.1% | 137,169 | -6.4% | 0.00% | 0.0% |
| Q4 2022 | $464,061 | +14.9% | 146,569 | +7.8% | 0.00% | 0.0% |
| Q3 2022 | $404,000 | -1.9% | 136,019 | +0.7% | 0.00% | 0.0% |
| Q2 2022 | $412,000 | -77.3% | 135,019 | +0.4% | 0.00% | -75.0% |
| Q1 2022 | $1,817,000 | +3.2% | 134,519 | -0.4% | 0.00% | +33.3% |
| Q4 2021 | $1,761,000 | +43.5% | 135,119 | +3.2% | 0.00% | 0.0% |
| Q3 2021 | $1,227,000 | -8.5% | 130,894 | -0.1% | 0.00% | 0.0% |
| Q2 2021 | $1,341,000 | +380.6% | 130,994 | +762.9% | 0.00% | +200.0% |
| Q1 2021 | $279,000 | -43.4% | 15,180 | +5.6% | 0.00% | 0.0% |
| Q4 2020 | $493,000 | +24550.0% | 14,380 | +14280.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 714,763 | $2,265,799 | 2.16% |
| Perceptive Advisors | 4,797,278 | $15,207,371 | 0.43% |
| Potomac Capital Management, Inc. | 80,000 | $254 | 0.30% |
| Bristlecone Advisors, LLC | 696,629 | $2,208,314 | 0.27% |
| TANG CAPITAL MANAGEMENT LLC | 485,234 | $1,538,192 | 0.22% |
| RA Capital Management | 1,881,300 | $5,963,721 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 270,989 | $859 | 0.11% |
| PATHSTONE FAMILY OFFICE, LLC | 3,631,080 | $8,182,650 | 0.07% |
| Laird Norton Wetherby Trust Company, LLC | 130,000 | $412,100 | 0.06% |
| Forefront Analytics, LLC | 22,350 | $70,851 | 0.04% |